legislation: 117-s-5123

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id	congress	bill_type	bill_number	title	policy_area	introduced_date	latest_action_date	latest_action_text	origin_chamber	sponsor_name	sponsor_state	sponsor_party	sponsor_bioguide_id	cosponsor_count	summary_text	update_date	url
117-s-5123	117	s	5123	Breakthrough Therapies Act	Crime and Law Enforcement	2022-11-17	2022-11-17	Read twice and referred to the Committee on the Judiciary.	Senate	Sen. Booker, Cory A. [D-NJ]	NJ	D	B001288	1	Breakthrough Therapies Act This bill provides for the classification of drugs or other substances that are part of approved breakthrough therapies as schedule II controlled substances under the Controlled Substances Act. It also provides for expedited controlled substance registrations through the Drug Enforcement Administration for researchers whose work involves investigational drugs.	2023-09-01T18:30:31Z

Links from other tables

2 rows from bill_id in legislation_actions
0 rows from bill_id in legislation_subjects
1 row from bill_id in legislation_cosponsors
0 rows from bill_id in cbo_cost_estimates